Webinar

Evaluation, Treatment, and Non-Stigmatizing Care for Adolescents with Obesity: Critical Components of Future Health

Launch Date
06/28/2023
Credit Amount
1.0
Credit Expires
06/28/2024

Faculty

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Obesity Medicine Physician Scientist
Massachusetts General Hospital
Associate Professor of Medicine and Pediatrics
Harvard Medical School
Boston, MA
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS

Dr. Stanford is an Associate Professor of Medicine and Pediatrics who practices and teaches at Massachusetts General Hospital (MGH)/ Harvard Medical School (HMS) as one of the first fellowship-trained obesity medicine physicians worldwide. She is among the most highly cited obesity medicine physician-scientists with over 170 peer-reviewed publications. Dr. Stanford received her BS and MPH from Emory University as an MLK Scholar, her MD from the Medical College of Georgia School of Medicine as a Stoney Scholar, her MPA from the Harvard Kennedy School of Government as a Zuckerman Fellow in the Harvard Center for Public Leadership and her executive MBA as a merit-based scholarship recipient from the Quantic School of Business and Technology. She completed her Obesity Medicine & Nutrition Fellowship at MGH/HMS after completing her internal medicine and pediatrics residency at the University of South Carolina. She has served as a health communications fellow at the Centers for Disease Control and Prevention and as a behavioral sciences intern at the American Cancer Society. Upon completing her MPH, she received the Gold Congressional Award, the highest honor Congress bestows upon America’s youth.

Dr. Stanford has completed a medicine and media internship at the Discovery Channel. An American Medical Association (AMA) Foundation Leadership Award recipient in 2005 and an AMA Paul Ambrose Award for national leadership among resident physicians in 2009, she was selected for the AMA Inspirational Physician Award in 2015. The American College of Physicians (ACP) selected her as the 2013 Joseph E. Johnson Leadership Award recipient, and the Massachusetts ACP selected her for the Young Leadership Award in 2015. She is the 2017 recipient of the HMS Amos Diversity Award and the Massachusetts Medical Society (MMS) Award for Women’s Health. In 2019, she was selected as the Suffolk District Community Clinician of the Year for the Reducing Health Disparities Award for MMS. She was chosen for The Obesity Society Clinician of the Year in 2020. In 2021, she was awarded the MMS Grant Rodkey Award for her dedication to medical students and the AMA Dr. Edmond and Rima Cabbabe Dedication to the Profession Award, which recognizes a physician who demonstrates active and productive improvement to the profession of medicine through community service, advocacy, leadership, teaching, or philanthropy. She is the 2021 Recipient of the Emory Rollins School of Public Health Distinguished Alumni Award. In 2022, the National Academy of Medicine selected her as a Scholar in Diagnostic Excellence. She was named to the 2025 Dietary Guidelines Advisory Committee by the US Department of Health and Human Services (HHS) and Agriculture (USDA).

 

Angela Golden, DNP, FNP-C, FAANP, FOMA
Owner and Provider, NP Obesity Treatment Clinic
Flagstaff, AZ
Angela Golden, DNP, FNP-C, FAANP, FOMA

Dr. Angie Golden is a current fellow and past president of the American Association of Nurse Practitioners (AANP). She owns NP Obesity Treatment Clinic in Flagstaff, AZ, where she provides evidence-based obesity treatment. She earned the Obesity Medical Association (OMA) NP/PA Certificate of Advanced Clinical Education and the Specialist Certification of Obesity Professional Education, an internationally recognized certification.

Dr. Golden has a great deal of experience as a consultant in the development of patient education materials; authored a book, Treating Obesity in Primary Care, and several book chapters on obesity management; written several peer-reviewed articles and participated in research; and been interviewed by lay media on obesity treatment. She presents nationally and internationally with an emphasis on obesity, health policy, leadership, and clinical care.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

There are now nearly 15 million children in the United States with obesity, reflecting a steep trajectory over the past few decades that firmly establish it both as a chronic disease and a critical health imperative. In 2023, the American Academy of Pediatrics (AAP) joined other organizations by releasing practice guidelines to emphasize obesity as a chronic disease, not a failure of character or willpower, that is linked to a complex pathophysiology involving energy balance dysregulation and organ system impairment. The new guidelines provide pathways that may include a combination of behavioral changes (eg, nutritious food, ample physical activity) with a choice of FDA-approved agents for managing obesity in adolescents, including semaglutide, liraglutide, orlistat, and phentermine/topiramate ER. Indications for bariatric surgery are also outlined.

This educational webcast titled, Evaluation, Treatment, and Non-Stigmatizing Care for Adolescents with Obesity, will feature expert faculty leading a conversation on how to achieve an equitable, universal approach to treating patients with obesity in the pediatric setting.  The discussion will provide learners with a plan to evaluate patients, consider their social determinants of health, initiate appropriate therapies, and monitor treatment. Strategies to implement shared decision-making and other empathetic communications will encourage long-term patient engagement.

Learning Objectives

  • Implement AAP guidelines for evaluating adolescents with obesity in pediatric practice.
  • Apply evidence-based pathways for initiating, monitoring, and continuing therapy for adolescents with obesity.
  • Engage in empathetic, non-stigmatizing communication with adolescents about long-term weight management.

Financial Support

Supported by an educational grant from Novo Nordisk, Inc.

Target Audience

Physicians, pharmacists, nurse practitioners (NPs), and physician associates (PAs) specializing in pediatrics.

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional (IPCE) 1.0

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) Credit for learning and change.

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.0

This activity is designated for 1.0 contact hour.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Pharmacists (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN : JA0007185-0000-23-057-H01-P

PAs (AAPA) 1.0

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until the expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Golden reports the following financial relationships:

Advisory Board: Acella Pharmaceuticals, LLC; Currax Pharmaceuticals LLC; Gelesis; Lilly; Novo Nordisk; and WW International, Inc.

Consultant: SetPoint Medical

Speakers Bureau: Acella Pharmaceuticals, LLC; Currax Pharmaceuticals LLC; and Novo Nordisk

Other financial or material support: Royalties from Springer

Dr. Stanford reports the following financial relationships:

Consultant: Boehringer Ingelheim; Calibrate Health, Inc.; Currax Pharmaceuticals LLC.; Gelesis; LifeForce; Lilly; Novo Nordisk; Pfizer Inc.; Rhythm Pharmaceuticals, Inc.; Sweetch; Veri Inc.; and Vida Health

Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:

  • Joshua Caballero PharmD, BCPP, FCCP (peer reviewer)
  • Evan Luberger (planning committee)
  • Warren Beckman (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

WCV-071-062823-68

Evaluation, Treatment, and Non-Stigmatizing Care for Adolescents with Obesity: Critical Components of Future Health
Event Date: 06/28/2023
Register

Related Activities